Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Home infusion therapy with iloprost using a portable syringe pump in systemic sclerosis
2013-004596-12Phase 2Completed
- Sponsor
- Azienda Ospedaliero-Universitaria delle Marche
- Start
- Dec 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of iloprost in Raynaud disease and systemic sclerosis (SSc), sponsored by Azienda Ospedaliero-Universitaria delle Marche. Primary endpoint: Treatment completion rate. Started Dec 2013; status: completed.
02
Drugs
iloprost
03
Conditions
Raynaud diseasesystemic sclerosis (SSc)
Beyond the preview
Go deeper on 2013-004596-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004596-12.